Watanabe Takuya, Temma Yuichi, Okada Junichi, Yamada Eijiro, Saito Tsugumichi, Okada Kazuya, Nakajima Yasuyo, Ozawa Atsushi, Takamizawa Tetsuya, Horigome Mitsuaki, Okada Shuichi, Yamada Masanobu
Department of Endocrinology and Metabolism, Saku Central Hospital Advanced Care Center, Japan.
Department of Medicine, Division of Endocrinology, Albert Einstein College of Medicine, USA.
J Rural Med. 2021 Apr;16(2):98-101. doi: 10.2185/jrm.2020-060. Epub 2021 Apr 1.
Because patients with diabetes mellitus (DM) were forced to stay indoors during the state of emergency, resulting in stress and a lack of physical activity, concerns about their glycemic control were raised. The 165 patients' glycated hemoglobin (HbA1c) levels were compared during the following periods: the 4 months that were selected as a representative condition 1 year before the COVID-19 pandemic (May 2018, March 2019, June 2019, and July 2019) and the latter 3 months as a 1-year follow-up during the COVID-19 pandemic (May 2019, March 2020, June 2020, and July 2020). The patients' HbA1c levels were 7.32 ± 1.23, 7.44 ± 1.20, 7.16 ± 1.06, 7.01 ± 1.05, 7.23 ± 1.06, 7.45 ± 1.18, 7.15 ± 10.7, and 7.11 ± 1.17 in May 2018, March 2019, June 2019, July 2019, May 2019, March 2020, June 2020, and July 2020, respectively (expressed as mean ± standard deviation). The analysis showed that HbA1c levels did not worsen during the self-restraint period.
由于糖尿病患者在紧急状态下被迫居家，导致压力增加且缺乏身体活动，人们对他们的血糖控制情况表示担忧。对165名患者在以下时间段的糖化血红蛋白（HbA1c）水平进行了比较：在2019年冠状病毒病大流行前1年选择4个月作为代表性状况（2018年5月、2019年3月、2019年6月和2019年7月），以及在2019年冠状病毒病大流行期间作为1年随访的后3个月（2019年5月、2020年3月、2020年6月和2020年7月）。患者在2018年5月、2019年3月、2019年6月、2019年7月、2019年5月、2020年3月、2020年6月和2020年7月的HbA1c水平分别为7.32±1.23、7.44±1.20、7.16±1.06、7.01±1.05、7.23±1.06、7.45±1.18、7.15±10.7和7.11±1.17（以平均值±标准差表示）。分析表明，在自我约束期间HbA1c水平并未恶化。
